Site Search
Google Search
search button

Breaking News:

Honduran Migrant Caravan Paused At Guatemala's Border With Mexico     - | -     Merkel Condemns Khashoggi's Killing     - | -     Russian Threat Still Prevalent     - | -     Saudi Arabia Admits Khashoggi Died In Consulate     - | -     Suicide Attack Kills 15 People In Afghan Capital On Election Day     - | -     Turkey Remains Steadfast Amidst Unraveling Khashoggi Case     - | -     Thousands Rally In Taiwan In Call For Independence From China     - | -     Mega Millions Hits Record Of $1.6 Billion     - | -     GOP Congressman Invokes 'The Deep State'
Pfizer Ends Research for New Alzheimer's, Parkinson's Drugs
Get Business & Technology Alerts

viewsViews 1183
7 Jan 2018 07:37 PM EST

NEW YORK (Reuters) - Pfizer Inc (PFE.N) is abandoning research to find new drugs aimed at treating Alzheimer’s and Parkinson’s disease, the U.S. pharmaceutical company announced on Saturday. The company said it expects to eliminate 300 positions from the neuroscience discovery and early development programs in Andover and Cambridge, Massachusetts, and Groton, Connecticut, as it redistributes the money spent on research, according to the emailed statement. Pfizer is not making any changes to research and development funding for tanezumab, which is marketed as a treatment for joint pain from osteoarthritis, fibromyalgia treatment Lyrica, or its rare disease program.

Post Your Comment
Excellent Very Good Good Fair Poor



Recently Posted Comments
FREE
AllMediaNY AllMediaNY AllMedaiNY